These two – the new Renault 4 and Ford Puma Gen-E – are the result of polar opposite strategies. One’s a ground-up effort on a bespoke platform from a brand that’s smashed its EVs out of the park ...

Take a mesmerizing journey through the physics and emotion of sound, guided by voices like Julius Sumner Miller, Brian Greene ...

This article shares valuable advice from seasoned leaders who have mastered the art of building trust, fostering growth, and ...

"A House of Dynamite" artisans relied on Volker Bertelmann's score to create tension and anxiety in Netflix's thriller.

Donald Trump has sparked a fresh frenzy about his health after giving a very unorthodox CNN interview. The 79-year-old president gave an exclusive interview to State of the Union host Jake Tapper ...

LOUISVILLE, Ky. — Kentucky has largely missed the wave of hyper-scale data centers. These large warehouses hold servers and computers to store data for companies, and also power artificial ...

Mr. Shenk is a historian of modern American politics and has written extensively about the fight for control of the Democratic Party. This essay is the first installment in a series on the thinkers, ...

Dogs do it, cats do it, deer do it – in fact, many species of mammals can swivel their ears to direct their hearing. Humans lost this ability about 25 million years ago, but according to a new study, ...

Genoa’s Salone Nautico is not the boating industry’s largest showcase – that title is held by its rival to the west, the Monaco Yacht Show, which follows it by scarcely a week every September. But the ...

The Hartford Insurance Group remains a compelling investment, considering its small business segment's growth and a disciplined capital management strategy. HIG's expansion in small business insurance ...

Former Vice President Kamala Harris said she isn’t focused on the 2028 presidential campaign when pressed on whether she would consider running for the White House again. Harris was asked during an ...

Pandemic-era favorites such as Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) will be under scrutiny after President Donald Trump on Monday urged the companies to justify the success of their COVID-19 ...